Details for 2019844315

Up to date per 04.04.2026

Actions

Title / Product Name

KOMBINATIONSPRODUKT AUS EINEM BCL-2-HEMMER UND IBRUTINIB ZUR VORBEUGUNG UND/ODER BEHANDLUNG VON KREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2019844315

EP Publication Number

3672639

E-Number

1469908

Language

PCT Number

CN19098252

Publication Date

01.07.2020 A

23.02.2022 B1

Registration Date

23.02.2022

AT Publication Date

15.03.2022

Application Date

30.07.2019

Registration Number

Priorities

31.07.2018

201810867251

IPC

A61K 31/519 20060101AFI20200824BHEP

Maximum Duration of Protection

30.07.2039

Owner

Ascentage Pharma (Suzhou) Co., Ltd.Unit 701, Building B7, 218 Xinghu Street Suzhou Industrial Park Suzhou, Jiangsu 215000CN

Representative

No representatives present

Inventor

YANG, DajunUnit 701, Building B7, 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN

ZHAI, YifanUnit 701, Building B7, 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN

FANG, Douglas DongUnit 701, Building B7, 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN

WANG, GuangfengUnit 701, Building B7, 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN

ZHAI, GuoqinUnit 701, Building B7, 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN